BRD2 and ovarian hyperstimulation syndrome: Increased FSH bioactivity (above 10 IU/L) and a bioactivity/immunoreactivity ration of 1.2–1.3 has been estimated in a young female with FSH-secreting adenoma and OHSS [9].